NuraLogix Releases Long-Term Cardiovascular Risk Assessment Model
FDA-cleared and clinically-validated app lets Venu 2 Plus customers record an ECG and check for signs of atrial fibrillation…
Leadership appointment builds on Nabla’s enterprise momentum and positions the company for its next phase of clinical AI deployment…
ARMONK, N.Y. and MORGANTOWN, W.Va., June 12, 2017 /PRNewswire/ — IBM (NYSE: IBM) and West Virginia University’s Center for…
TORONTO — Aug. 14, 2025 — NuraLogix, a leader in contactless wellness monitoring, has launched the Anura® Anxiety Index,…
New Waystar capabilities aim to reduce claim denials, improve payment collections and automate revenue cycle workflows. AdvancedMD has expanded…